Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Orlic-Milacic, Marija, 2017-12-03
| Class:Id | InstanceEdit:9031775 |
|---|
| _displayName | Orlic-Milacic, Marija, 2017-12-03 |
|---|
| _timestamp | 2017-12-03 14:13:46 |
|---|
| author | [Person:1169272] Orlic-Milacic, Marija |
|---|
| dateTime | 2017-12-03 19:12:03 |
|---|
| (modified) | [CatalystActivity:1433507] 1-phosphatidylinositol-3-kinase activity of PI3K:p-KIT:sSCF dimer:p-KIT,PI3K:p(Y)-GAB2:GRB2:p-SHP2:p-KIT complex [plasma membrane]
[Reaction:1433514] Synthesis of PIP3 from PIP2 by PI3K [Homo sapiens]
[PathwayDiagram:1448706] Diagram of Signaling by SCF-KIT, Signaling by juxtamembrane domain KIT mutants, Signaling by extracellular domain mutants of KIT, Signaling by kinase domain mutants of KIT, Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants, KIT mutants bind TKIs, Imatinib-resistant KIT mutants, Sunitinib-resistant KIT mutants, Regorafenib-resistant KIT mutants, Sorafenib-resistant KIT mutants, Nilotinib-resistant KIT mutants, Masitinib-resistant KIT mutants, and Dasatinib-resistant KIT mutants
[Complex:1562561] PI3K:p(Y)-GAB2:GRB2:p-SHP2:p-KIT complex [plasma membrane] [Homo sapiens] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Orlic-Milacic, Marija, 2017-12-03 (9031775)
